Protocol for a pilot randomised controlled trial of zoledronic acid to prevent bone loss following sleeve gastrectomy surgery
Introduction Sleeve gastrectomy (SG) is an increasingly used and effective treatment for obesity; however, the rapid weight loss associated with SG adversely affects bone metabolism predisposing patients to skeletal fragility. Bisphosphonate medications have been evaluated for safety and efficacy in...
Saved in:
| Main Authors: | Laura E Flores, Lynn Mack, Christopher Wichman, Ashley A Weaver, Vishal Kothari, Laura D Bilek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/12/e057483.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonhealing abdominal ulcer after robotic sleeve gastrectomy
by: Julia Gomez, BS, et al.
Published: (2025-01-01) -
Splenic Abscess after Sleeve Gastrectomy
by: Rany Aoun, et al.
Published: (2020-01-01) -
Sleeve Gastrectomy and Gastroesophageal Reflux Disease
by: Michael Laffin, et al.
Published: (2013-01-01) -
Levothyroxine malabsorption following sleeve gastrectomy
by: Elodie Gruneisen, et al.
Published: (2025-01-01) -
Late Complication of Laparoscopic Sleeve Gastrectomy
by: Anthony Dakwar, et al.
Published: (2013-01-01)